RÁČIL, Zdeněk, Martina TOŠKOVÁ, Dana DVOŘÁKOVÁ, Ivana JEŽÍŠKOVÁ, Filip RÁZGA, Lucie BUREŠOVÁ, Shira TIMILSINA and Jiří MAYER. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy. American Journal of Hematology. MALDEN, USA: WILEY-BLACKWELL, 2012, vol. 87, No 2, p. 211-213. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.22213.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy
Name in Czech Terapie molekulárního relapsu u pacientů s akutní myeloidní leukemií pomocí clofarabinu v monoterapii
Authors RÁČIL, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), Martina TOŠKOVÁ (703 Slovakia, belonging to the institution), Dana DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution), Ivana JEŽÍŠKOVÁ (203 Czech Republic), Filip RÁZGA (703 Slovakia, belonging to the institution), Lucie BUREŠOVÁ (203 Czech Republic, belonging to the institution), Shira TIMILSINA (524 Nepal, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution).
Edition American Journal of Hematology, MALDEN, USA, WILEY-BLACKWELL, 2012, 0361-8609.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.138
RIV identification code RIV/00216224:14740/12:00059099
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/ajh.22213
UT WoS 000299098100023
Keywords (in Czech) molekulární relaps; AML; clofarabin v monoterapii
Keywords in English molecular relapse; AML; clofarabine monotherapy
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 7/4/2013 14:39.
Abstract
Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.
Abstract (in Czech)
Jen málo studií se zabývalo léčbou molekulární relapsu u pacientů s akutní myeloidní leukémie (AML) s použitím rozdílných režimů. Popíšeme poprvé v literatuře zkušenosti s podáváním clofarabinu (monoterapie) při léčbě osmi pacientů s AML s molekulárním relapsem onemocnění.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 22/8/2024 23:20